Andrea R. Yoder, Ph.D. - Publications

2010 Pharmacology University of Minnesota, Twin Cities, Minneapolis, MN 
Pharmacology, Biochemistry

5 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any innacuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2012 Yoder AR, Robinson JW, Dickey DM, Andersland J, Rose BA, Stone MD, Griffin TJ, Potter LR. A functional screen provides evidence for a conserved, regulatory, juxtamembrane phosphorylation site in guanylyl cyclase a and B. Plos One. 7: e36747. PMID 22590601 DOI: 10.1371/journal.pone.0036747  0.44
2010 Yoder AR, Stone MD, Griffin TJ, Potter LR. Mass spectrometric identification of phosphorylation sites in guanylyl cyclase A and B. Biochemistry. 49: 10137-45. PMID 20977274 DOI: 10.1021/bi101700e  0.44
2009 Dickey DM, Yoder AR, Potter LR. A familial mutation renders atrial natriuretic Peptide resistant to proteolytic degradation. The Journal of Biological Chemistry. 284: 19196-202. PMID 19458086 DOI: 10.1074/jbc.M109.010777  0.84
2009 Potter LR, Yoder AR, Flora DR, Antos LK, Dickey DM. Natriuretic peptides: their structures, receptors, physiologic functions and therapeutic applications. Handbook of Experimental Pharmacology. 341-66. PMID 19089336 DOI: 10.1007/978-3-540-68964-5_15  0.84
2008 Yoder AR, Kruse AC, Earhart CA, Ohlendorf DH, Potter LR. Reduced ability of C-type natriuretic peptide (CNP) to activate natriuretic peptide receptor B (NPR-B) causes dwarfism in lbab -/- mice. Peptides. 29: 1575-81. PMID 18554750 DOI: 10.1016/j.peptides.2008.04.020  0.84
Show low-probability matches.